Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease

Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease

Source: 
Fierce Biotech
snippet: 

Pfizer’s neuroscience spinoff, Cerevel Therapeutics, is bringing on Otsuka’s Raymond Sanchez, M.D., to serve as its new chief medical officer and take forward development of its late-stage programs for Parkinson’s disease and epilepsy into phase 3.